enGene Therapeutics Return on Net Operating Assets Insights

enGene Therapeutics, Inc. (ENGN)

1.64 -0.09 (-5.20%) USD | NASDAQ | May 22, 16:00

1.73 +0.09 (+5.49%) Pre-Market: 20:00

View Return on Net Operating Assets for ENGN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View Historical Data

Start Trial

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

Achieve Life Sciences, Inc.	Upgrade
Aurinia Pharmaceuticals, Inc.	Upgrade
Edesa Biotech, Inc.	Upgrade
Xenon Pharmaceuticals, Inc.	Upgrade
ProMIS Neurosciences, Inc.	Upgrade